US 11186626
Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11186626 (Broadly neutralizing antibody targeting the ebolavirus glycoprotein internal fusion loop) held by INTEGRATED BIOTHERAPEUTICS, INC. expires Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- INTEGRATED BIOTHERAPEUTICS, INC.
- Grant date
- Tue Nov 30 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K39/42, A61K47/6841